Miramar Resources Limited (ASX:M2R) has disclosed changes to the relevant interests of two directors, Allan Kelly and Mark Hanlon, following their participation in a placement that received shareholder approval on 19 November 2026.

Key Points

  • Director Allan Kelly acquired 28,571,429 ordinary shares on 19 November 2026 for consideration of $50,000 via placement participation through Allorah Pty Ltd.
  • Director Mark Hanlon acquired 114,285,714 ordinary shares on 19 November 2026 for consideration of $200,000 via placement participation through Buprestid Pty Ltd.
  • Following the change, Kelly's indirect holding through Allorah Pty Ltd increased to 89,207,687 ordinary shares, with options across two series unchanged.
  • Following the change, Hanlon's indirect holding through Buprestid Pty Ltd increased to 222,860,374 ordinary shares, with options across two series unchanged.

Allan Kelly Placement Participation and Updated Shareholding

According to the filing, Allan Kelly's interest in ordinary shares changed on 19 November 2026 upon receipt of shareholder approval for placement participation. The acquisition of 28,571,429 ordinary shares, held indirectly via Allorah Pty Ltd under the Kelly SF A/C, was made for consideration of $50,000. Following the change, Kelly holds no direct ordinary shares, with indirect holdings via XGS Pty Ltd at 19,608,073 shares and via Debnal Pty Ltd at 16,666,667 shares remaining unchanged. Kelly also retains 2,000,000 unlisted options exercisable at $0.031 expiring 8 November 2027, held directly.

Mark Hanlon Placement Participation and Updated Shareholding

Mark Hanlon's relevant interest changed on 19 November 2026 following placement participation upon receipt of shareholder approval. Hanlon, through Buprestid Pty Ltd under the Hanlon Family S/F A/C, acquired 114,285,714 ordinary shares for consideration of $200,000, with no securities disposed. Prior to the change, Hanlon held 108,574,660 ordinary shares through that entity. His options remained unchanged, comprising 31,400,000 listed options exercisable at $0.018 expiring 25 July 2027 and 80,000,000 unlisted options exercisable at $0.004 expiring 13 March 2028, all held indirectly.

Option Holdings and Closed Period Disclosure

The filings confirm that neither director traded securities during a closed period requiring prior written clearance. For Allan Kelly, options on issue include 2,000,000 unlisted options exercisable at $0.031 expiring 8 November 2027, 9,583,334 listed options exercisable at $0.018 expiring 25 July 2027, and 10,000,000 unlisted options exercisable at $0.004 expiring 13 March 2028. The filings state no interests in contracts were subject to change for either director, with all relevant contract fields recorded as not applicable. The date of both filings is recorded as 19 November 2026.